DES Follow-up Clinic
Monitoring women whose mothers took the drug Diethyl Stilboestrol (DES) during their pregnancy.
For women whose mothers took the drug Diethyl Stilboestrol (DES) during their pregnancy we provide the following services:
- Colposcopy of cervix and vagina
- Gynaecological assessment
- Management of menopausal issues
- Women who took DES
- Women whose mothers took DES during their pregnancy
- Women whose mothers did not take DES during their pregnancy
The women will attend an annual follow up unless an abnormality is found on a cervical smear and then followed up more frequently.
Triage staff may assign your referral to a clinic with a shorter waiting time and most appropriate speciality focus. More comprehensive referrals are usually seen more quickly.
Please include "History of DES exposure in utero" in your referral*
* often history is uncertain and patients want clarification as to whether they are likely to be exposed or not.
Please complete and fax the Fast Fax Referral form
Please contact the DES follow-up clinic enquiries number for all DES related issues.
The GP will receive notification about whether the referral has been accepted. The patient will then receive a letter with the appointment details.
Downloads and Related Topics
This information is for women who have recently been informed that they may have been exposed to DES (di-ethyl-stilboestrol or stilboestrol). This DES exposure fact sheet discusses the importance of being under the care of medical professionals experienced in DES exposed women and the treatments and examinations they will need.
- DES exposure
A colposcopy is an examination which is recommended after some positive or abnormal cervical screening test results. Your local doctor (GP) will discuss these results with you. After a colposcopy, decisions can be made about whether treatment is needed or not.